Melincoff Gwen A (CIK 1614890) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-09-04). Recent activity: Buy PLX (7,500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-09-04 | Protalix BioTherapeutics, Inc. (PLX) | Director | Buy | 7,500 | $0 |
来源：SEC Form 4 申报文件 · 截至 2025-09-04